The NCCN ORP fosters innovation and knowledge discovery that improve the lives of patients with cancer.
Guiding Principles:
NCCN and AstraZeneca Quality Improvement Initiative: Quality Improvement in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) Research Grant Opportunity - Submit Proposals by 5:00 pm ET on Thursday, July 18, 2024. Open to NCCN Member Institutions Only.
NCCN and Pfizer Investigator Sponsored Research for Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPi in the Treatment of Prostate Cancer – Submit Proposal by 5:00 pm ET on Tuesday, July 23, 2024. Open to NCCN Member Institutions Only.
View the NCCN ORP Press Releases
View the NCCN ORP Scientific Publications
View the NCCN ORP Disclosure Policy